Fermenta Biotech has received the Certificate of Suitability (CEP) from European Directorate for the Quality of Medicines & Healthcare (EDQM) for its Spray?Dried variant, Vitadee 100 SD - Cholecalciferol Concentrate (powder form) 100, 000 IU/g being manufactured at its Kullu, Himanchal Pradesh facility.
Fermenta now becomes one of the only two companies globally to hold a CEP for this variant of Vitamin?D3. The approval underscores Fermenta’s adherence to the stringent European Pharmacopoeial Standards for manufacturing and product quality. This recognition further enhances Fermenta’s international footprint and its capability to deliver products that meet the highest global quality and regulatory standards. It represents another step forward in company’s mission to expand its global presence and create meaningful impact across the health and nutrition industry.
Fermenta Biotech possesses a growing portfolio of nutrition including customized Premixes, Fortified Rice Kernel (FRK) and other nutritional ingredients. Apart from its nutrition portfolio, the company is one of the world’s leading manufacturers of Vitamin D3.
